Value Bridge — NEW HANOVER REGIONAL MEDICAL CENTER
Current $-237M → Target $-210M (+$27.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-237.4M
Current EBITDA
$-210.3M
Target EBITDA
+$27.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$6.1M
Payer Mix Optimization
$14.7M
Cost to Collect Reduction
$4.9M
Clean Claim Improvement
$3.7M
Volume & Rate Growth
$24.5M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-237M to $-210M. The highest-impact lever is Volume & Rate Growth at $9.8M probability-weighted.
IC talking point: "We see $27M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $298M in equity value creation."